{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:33:38Z","timestamp":1791999218485,"version":"4.4.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.path.2025.01.002","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T07:30:03Z","timestamp":1739863803000},"page":"513-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Phosphaturic Mesenchymal Tumors"],"prefix":"10.1016","volume":"18","author":[{"given":"Yu-Ju","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Chieh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2025.01.002_bib1","series-title":"World health organization classification of tumours of soft tissue and bone tumors","first-page":"284","article-title":"Phosphaturic mesenchymal tumour","author":"Lee","year":"2020"},{"issue":"1","key":"10.1016\/j.path.2025.01.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2025.01.002_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00041552-200209000-00011","article-title":"New insights into phosphate homeostasis: fibroblast growth factor 23 and frizzled-related protein-4 are phosphaturic factors derived from tumors associated with osteomalacia","volume":"11","author":"Kumar","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1016\/j.path.2025.01.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00355.x","article-title":"The phosphatonin pathway: new insights in phosphate homeostasis","volume":"65","author":"Schiavi","year":"2004","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.path.2025.01.002_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/er.2005-0019","article-title":"The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23","volume":"27","author":"White","year":"2006","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.path.2025.01.002_bib6","first-page":"33","article-title":"Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years","volume":"16","author":"McCance","year":"1947","journal-title":"Q J Med"},{"key":"10.1016\/j.path.2025.01.002_bib7","first-page":"554","volume":"14","author":"Prader","year":"1959","journal-title":"Helv Paediatr Acta"},{"issue":"7746","key":"10.1016\/j.path.2025.01.002_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(72)92844-9","article-title":"Distinctive tumours of bone and soft tissue causing acquired vitamin-D-resistant osteomalacia","volume":"1","author":"Evans","year":"1972","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.path.2025.01.002_bib9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJM197204062861402","article-title":"\"Tertiary\" hyperparathyroidism and apparent \"cure\" of vitamin-D-resistant rickets after removal of an ossifying mesenchymal tumor of the pharynx","volume":"286","author":"Olefsky","year":"1972","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.path.2025.01.002_bib10","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","article-title":"Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets","volume":"59","author":"Weidner","year":"1987","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.path.2025.01.002_bib11","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","article-title":"Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2025.01.002_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.4465","article-title":"Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour","volume":"235","author":"Lee","year":"2015","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.path.2025.01.002_bib13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/j.semdp.2019.07.002","article-title":"Phosphaturic mesenchymal tumors: a review and update","volume":"36","author":"Folpe","year":"2019","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"10.1016\/j.path.2025.01.002_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2500\/ar.2014.5.0100","article-title":"Sinonasal phosphaturic mesenchymal tumor: case report and systematic review","volume":"5","author":"Deep","year":"2014","journal-title":"Allergy Rhinol (Providence)"},{"issue":"2","key":"10.1016\/j.path.2025.01.002_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41379-018-0100-0","article-title":"Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review","volume":"32","author":"Wu","year":"2019","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2025.01.002_bib16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12105-015-0668-3","article-title":"Phosphaturic mesenchymal tumor: 2 new oral cases and review of 53 cases in the head and neck","volume":"10","author":"Qari","year":"2016","journal-title":"Head Neck Pathol"},{"issue":"1","key":"10.1016\/j.path.2025.01.002_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.psym.2011.01.002","article-title":"Psychotic disorder due to phosphaturic mesenchymal tumor with mixed connective tissue variant","volume":"53","author":"Shih","year":"2012","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1016\/j.path.2025.01.002_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s100240050008","article-title":"Phosphaturic mesenchymal tumor-induced rickets","volume":"3","author":"Reyes-M\u00fagica","year":"2000","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.path.2025.01.002_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116064","article-title":"Challenges in the management of tumor-induced osteomalacia (TIO)","volume":"152","author":"Brandi","year":"2021","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.path.2025.01.002_bib20","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.path.2025.01.002_bib21","first-page":"429","article-title":"Late onset oncogenic osteomalacia-associated with neurofibromatosis type II","volume":"54","author":"Haviv","year":"2000","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1016\/j.path.2025.01.002_bib22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.path.2025.01.002_bib23","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaad.2015.11.012","article-title":"Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy","volume":"75","author":"Lim","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.path.2025.01.002_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0000000000000290","article-title":"A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors","volume":"39","author":"Carter","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2025.01.002_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000282746","article-title":"Prostate cancer-induced oncogenic hypophosphatemic osteomalacia","volume":"55","author":"Nakahama","year":"1995","journal-title":"Urol Int"},{"issue":"3","key":"10.1016\/j.path.2025.01.002_bib26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/jc.2012-3473","article-title":"Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma","volume":"98","author":"Leaf","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.path.2025.01.002_bib27","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.3390\/curroncol30080541","article-title":"Phosphaturic mesenchymal tumors with or without phosphate metabolism derangements","volume":"30","author":"Montanari","year":"2023","journal-title":"Curr Oncol"},{"issue":"3","key":"10.1016\/j.path.2025.01.002_bib28","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.path.2025.01.002_bib29","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jbmr.316","article-title":"Selective venous catheterization for the localization of phosphaturic mesenchymal tumors","volume":"26","author":"Andreopoulou","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.path.2025.01.002_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00256-018-3014-5","article-title":"Imaging features of phosphaturic mesenchymal tumors","volume":"48","author":"Broski","year":"2019","journal-title":"Skeletal Radiol"},{"issue":"6","key":"10.1016\/j.path.2025.01.002_bib31","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s13139-018-0546-5","article-title":"Successful localization using 68Ga-DOTATOC PET\/CT of a phosphaturic mesenchymal tumor causing osteomalacia in a patient with concurrent follicular lymphoma","volume":"52","author":"Ha","year":"2018","journal-title":"Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.path.2025.01.002_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s43465-019-00005-5","article-title":"Phosphaturic mesenchymal tumors from head to toe: imaging findings and role of the radiologist in diagnosing tumor-induced osteomalacia","volume":"54","author":"Kawthalkar","year":"2020","journal-title":"Indian J Orthop"},{"issue":"12","key":"10.1016\/j.path.2025.01.002_bib33","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.radcr.2019.09.027","article-title":"Phosphaturic mesenchymal tumor: case report","volume":"14","author":"Richardson","year":"2019","journal-title":"Radiol Case Rep"},{"issue":"9","key":"10.1016\/j.path.2025.01.002_bib34","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/PAS.0b013e3181aa2311","article-title":"RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia","volume":"33","author":"Bahrami","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2025.01.002_bib35","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/his.13377","article-title":"Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant","volume":"72","author":"Yamada","year":"2018","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.path.2025.01.002_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100336","article-title":"Klotho overexpression is frequently associated with upstream rearrangements in fusion-negative phosphaturic mesenchymal tumors of bone and sinonasal tract","volume":"36","author":"Lee","year":"2023","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.path.2025.01.002_bib37","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/cup.12209","article-title":"Tumor-induced osteomalacia resulting from primary cutaneous phosphaturic mesenchymal tumor: a case and review of the medical literature","volume":"40","author":"Gardner","year":"2013","journal-title":"J Cutan Pathol"},{"issue":"10","key":"10.1016\/j.path.2025.01.002_bib38","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/000992288102001005","article-title":"Hypophosphatemic rickets in an adolescent cured by excision of a nonossifying fibroma","volume":"20","author":"Asnes","year":"1981","journal-title":"Clin Pediatr (Phila)"},{"issue":"1","key":"10.1016\/j.path.2025.01.002_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2169\/internalmedicine1962.21.35","article-title":"Vitamin D resistant hypophosphatemic osteomalacia associated with osteosarcoma of the mandible: report of a case","volume":"21","author":"Nomura","year":"1982","journal-title":"Jpn J Med"},{"issue":"10","key":"10.1016\/j.path.2025.01.002_bib40","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PAS.0000000000000890","article-title":"Phosphaturic mesenchymal tumors: clinicopathologic, immunohistochemical and molecular analysis of 22 cases expanding their morphologic and immunophenotypic spectrum","volume":"41","author":"Agaimy","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2025.01.002_bib41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1507\/endocrj.EJ16-0587","article-title":"The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases","volume":"64","author":"Feng","year":"2017","journal-title":"Endocr J"},{"issue":"2","key":"10.1016\/j.path.2025.01.002_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002560000306","article-title":"Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia","volume":"30","author":"Ogose","year":"2001","journal-title":"Skeletal Radiol"},{"issue":"11","key":"10.1016\/j.path.2025.01.002_bib43","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.humpath.2013.04.027","article-title":"Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis","volume":"44","author":"Uchihashi","year":"2013","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.path.2025.01.002_bib44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.anl.2008.01.003","article-title":"Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue","volume":"36","author":"Uramoto","year":"2009","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"10.1016\/j.path.2025.01.002_bib45","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1186\/s12891-021-04558-1","article-title":"Malignant phosphaturic mesenchymal tumor-ossifying fibroma-like subtype: a case report and literature review","volume":"22","author":"Qin","year":"2021","journal-title":"BMC Muscoskel Disord"},{"issue":"5","key":"10.1016\/j.path.2025.01.002_bib46","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/s41379-019-0416-4","article-title":"Frequent overexpression of klotho in fusion-negative phosphaturic mesenchymal tumors with tumorigenic implications","volume":"33","author":"Lee","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2025.01.002_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.956472","article-title":"Case report: novel NIPBL-BEND2 fusion gene identified in osteoblastoma-like phosphaturic mesenchymal tumor of the fibula","volume":"12","author":"Sakai","year":"2023","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.path.2025.01.002_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100266","article-title":"RNA sequencing reveals novel oncogenic fusions and depicts detailed fusion transcripts of FN1-FGFR1 in phosphaturic mesenchymal tumors","volume":"36","author":"Liu","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2025.01.002_bib49","article-title":"Tumor-induced osteomalacia due to a recurrent mesenchymal tumor overexpressing several growth factor receptors","volume":"2015","author":"Yavropoulou","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.path.2025.01.002_bib50","article-title":"Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets\/osteomalacia (TIO)","volume":"10","author":"Kinoshita","year":"2018","journal-title":"Bone Rep"},{"issue":"10","key":"10.1016\/j.path.2025.01.002_bib51","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/gcc.22764","article-title":"Genetic profiling of a chondroblastoma-like osteosarcoma\/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion","volume":"58","author":"Saba","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"issue":"7","key":"10.1016\/j.path.2025.01.002_bib52","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41379-021-00786-x","article-title":"Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis","volume":"34","author":"Liu","year":"2021","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2025.01.002_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.path.2023.06.006","article-title":"Calcified chondroid mesenchymal neoplasms","volume":"17","author":"Kao","year":"2024","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.path.2025.01.002_bib54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13000-016-0477-3","article-title":"Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant","volume":"11","author":"Shiba","year":"2016","journal-title":"Diagn Pathol"},{"issue":"9","key":"10.1016\/j.path.2025.01.002_bib55","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-021919","article-title":"Clinical case seminar: fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia","volume":"88","author":"Nelson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.path.2025.01.002_bib56","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.humpath.2013.07.016","article-title":"Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A)","volume":"44","author":"Houang","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2025.01.002_bib57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.humpath.2018.02.022","article-title":"Phosphaturic mesenchymal tumor without osteomalacia: additional confirmation of the \"nonphosphaturic\" variant, with emphasis on the roles of FGF23 chromogenic in situ hybridization and FN1-FGFR1 fluorescence in situ hybridization","volume":"80","author":"Sent-Doux","year":"2018","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.path.2025.01.002_bib58","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/jclinpath-2012-200852","article-title":"Frequent expression of fibroblast growth factor-23 (FGF23) mRNA in aneurysmal bone cysts and chondromyxoid fibromas","volume":"65","author":"Graham","year":"2012","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.path.2025.01.002_bib59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002560050581","article-title":"Oncogenic osteomalacia","volume":"29","author":"Sundaram","year":"2000","journal-title":"Skeletal Radiol"},{"issue":"6","key":"10.1016\/j.path.2025.01.002_bib60","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/PAS.0000000000002044","article-title":"Calcified chondroid mesenchymal neoplasm: exploring the morphologic and clinical features of an emergent entity with a series of 33 cases","volume":"47","author":"Kallen","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.path.2025.01.002_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100598","article-title":"Chondroid synoviocytic neoplasm: a clinicopathologic, immunohistochemical, and molecular genetic study of a distinctive tumor of synoviocytes","volume":"37","author":"Kao","year":"2024","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.path.2025.01.002_bib62","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/s41379-019-0315-8","article-title":"Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement","volume":"32","author":"Amary","year":"2019","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2025.01.002_bib63","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/path.4683","article-title":"FN1-EGF gene fusions are recurrent in calcifying aponeurotic fibroma","volume":"238","author":"Puls","year":"2016","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.path.2025.01.002_bib64","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/path.5216","article-title":"Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone","volume":"248","author":"Baumhoer","year":"2019","journal-title":"J Pathol"},{"issue":"5","key":"10.1016\/j.path.2025.01.002_bib65","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)63432-3","article-title":"USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts","volume":"165","author":"Oliveira","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.path.2025.01.002_bib66","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12891-016-1004-0","article-title":"Non-ossifying fibroma: natural history with an emphasis on a stage-related growth, fracture risk and the need for follow-up","volume":"17","author":"Herget","year":"2016","journal-title":"BMC Muscoskel Disord"},{"issue":"5","key":"10.1016\/j.path.2025.01.002_bib67","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ng.2927","article-title":"GRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma","volume":"46","author":"Nord","year":"2014","journal-title":"Nat Genet"},{"issue":"13","key":"10.1016\/j.path.2025.01.002_bib68","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2106\/JBJS.N.01299","article-title":"Surgical treatments of tumor-induced osteomalacia lesions in long bones: seventeen cases with more than one year of follow-up","volume":"97","author":"Wang","year":"2015","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.path.2025.01.002_bib69","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.anl.2017.05.006","article-title":"Phosphaturic mesenchymal tumor of the nasal cavity and paranasal sinuses: a clinical curiosity presenting a diagnostic challenge","volume":"45","author":"Kane","year":"2018","journal-title":"Auris Nasus Larynx"},{"issue":"11","key":"10.1016\/j.path.2025.01.002_bib70","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.path.2025.01.002_bib71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/CH-200921","article-title":"Application of ultrasound-guided biopsy and percutaneous radiofrequency ablation in 2 cases with phosphaturic mesenchymal tumor and literature review","volume":"77","author":"Xian","year":"2021","journal-title":"Clin Hemorheol Microcirc"},{"issue":"9","key":"10.1016\/j.path.2025.01.002_bib72","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00198-020-05795-1","article-title":"Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation","volume":"32","author":"Horng","year":"2021","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.path.2025.01.002_bib73","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.path.2025.01.002_bib74","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00223-022-00987-9","article-title":"The measurement and interpretation of fibroblast growth factor 23 (FGF23) concentrations","volume":"112","author":"Heijboer","year":"2023","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"10.1016\/j.path.2025.01.002_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10661","article-title":"Infigratinib reduces fibroblast growth factor 23 (FGF23) and increases blood phosphate in tumor-induced osteomalacia","volume":"6","author":"Hartley","year":"2022","journal-title":"JBMR Plus"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918125000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918125000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T20:01:35Z","timestamp":1753473695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918125000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1875918125000029"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2025.01.002","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphaturic Mesenchymal Tumors","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2025.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}